Professional Documents
Culture Documents
Full Text
Full Text (PDF)
OA All Versions of this Article:
2/4/465 most recent
neh140v1
eCAM Advance Access originally published online on E-letters: Submit a response
October 27, 2005 E-letters: View responses
eCAM 2005 2(4):465-473; doi:10.1093/ecam/neh140 Alert me when this article is cited
Alert me when E-letters are posted
Alert me if a correction is posted
Services
Email this article to a friend
Similar articles in this journal
Similar articles in PubMed
Ayurveda and Traditional Alert me to new issues of the journal
Suchin Virabhak
affiliation not provided to SSRN
November 2002
Abstract:
Several econometric studies have concluded that technical progress embodied in equipment is a
major source of manufacturing productivity growth. Other research has suggested that, over the
long run, growth in the U.S. economy's 'health output' has been at least as large as the growth in
non-health goods and services. One important input in the production of health - pharmaceuticals
- is even more R&D-intensive than equipment.
In this paper we test the pharmaceutical-embodied technical progress hypothesis - the hypothesis
that newer drugs increase the length and quality of life - and estimate the rate of progress. To do
this, we estimate health production functions, in which the dependent variables are various
indicators of post-treatment health status (such as survival, perceived health status, and
presence of physical or cognitive limitations), and the regressors include drug vintage (the year in
which the FDA first approved a drug's active ingredient(s)) and indicators of pre-treatment health
status. We estimate these relationships using extremely disaggregated - prescription-level -
cross-sectional data derived primarily from the 1997 Medical Expenditure Panel Survey.
We find that people who used newer drugs had better post-treatment health than people using
older drugs for the same condition, controlling for pre-treatment health, age, sex, race, marital
status, education, income, and insurance coverage: they were more likely to survive, their
perceived health status was higher, and they experienced fewer activity, social, and physical
limitations. The estimated cost of the increase in vintage required to keep a person alive is lower
than some estimates of the value of remaining alive for one month. One estimate of the cost of
preventing an activity limitation is $1745, and the annual rate of technical progress with respect to
activity limitations is 8.4%. People consuming newer drugs tend to experience greater increases
(or smaller declines) in physical ability than people consuming older drugs.
Most of the health measures indicate that the effect of drug vintage on health is higher for people
with low initial health than it is for people with high initial health. Therefore in contrast to
equipment-embodied technical progress, which tends to increase economic inequality,
pharmaceutical-embodied technical progress has a tendency to reduce inequality as well as
promote economic growth, broadly defined.
http://papers.ssrn.com/sol3/papers.cfm?abstract_id=353761
5) Use of Herbal Medicines in Wound Healing: A
Perspective Paper
Terence J. Ryan, DM, FRCP
The International Journal of Lower Extremity Wounds, Vol. 2, No. 1, 22-24 (2003)
DOI: 10.1177/1534734603002001005
http://ijl.sagepub.com/cgi/content/abstract/2/1/22
Sheila McKay
Jim Gough
This exploratory study of student nurses is based on the results of the responses to one
question on an open-ended questionnaire: How would you define the relationship
between alternative medicine and allopathic (conventional) medicine? A specific goal of
the study was to find out how the surveyed respondents conceptualized the relationship
between allopathic and alternative medicine. Three themes were identified: (a) "They are
not at all alike," (b) "The two can or should be used together," and (c) "Those who
practice alternative medicine and those who practice allopathic do not get along very
well." The discussion suggests some reasons for these perceptions and considers some
implications for future health care.
http://wjn.sagepub.com/cgi/content/abstract/26/3/356
http://tps.sagepub.com/cgi/content/abstract/41/1/80
This Article
Full Text
Full Text (PDF)
E-letters: Submit a response
Alert me when this article is cited
Alert me when E-letters are posted
8) eCAM Advance Access published online on Alert me if a correction is posted
February 20, 2009
eCAM, doi:10.1093/ecam/nep005 Services
Email this article to a friend
Similar articles in this journal
© 2009 The Author(s). Published by Oxford University Similar articles in PubMed
Press. All rights reserved. For Permissions, please email: Alert me to new issues of the journal
journals.permissions@oxfordjournals.org
Add to My Personal Archive
Download to citation manager
Request Permissions
Review
Google Scholar
Articles by Datta, H. S.
Theories and Management of Articles by Patwardhan, B.
PubMed
Ayurveda Perspectives PubMed Citation
Articles by Datta, H. S.
Hema Sharma Datta1, S. K. Mitra2, Rangesh Articles by Patwardhan, B.
Paramesh2 and Bhushan Patwardhan1
Social Bookmarking
1
Interdisciplinary School of Health Sciences,
University of Pune, Pune-411007 and 2Himalaya What's this?
Health Care, Research & Development, Makali,
Bangalore 562 123, India
Aging is a complex phenomenon, a sum total of changes that occur in a living organism
with the passage of time and lead to decreasing ability to survive stress, increasing
functional impairment and growing probability of death. There are many theories of aging
and skin remains the largest organ of the study. Skin aging is described as a consequence
of intrinsic and extrinsic factors. The most common amongst visible signs of skin aging
are wrinkles and there are various therapies including antiaging cosmeceuticals,
sunscreens, chemical peeling, injectable agents, such as botox, fibrel, autologous fat
grafting as also few surgical procedures have been used. Ayurveda, the Indian traditional
medicine, describes aging with great details. This review provides modern and Ayurvedic
perspectives on theories and management of aging.
For reprints and all correspondence: Bhushan Patwardhan, PhD, Chief Academics,
Manipal Education, Manipal Towers, Bangalore 560 008, India. Tel: +919900566399;
Fax: +91 80 25202250; E-mail: bhushan.patwardhan@manipalu.com
Services
Email this article to a friend
Similar articles in this journal
Alert me to new issues of the journal
Add to My Personal Archive
Download to citation manager
Request Permissions
Google Scholar
Articles by Desai, P. N.
Search for Related Content
PubMed
Articles by Desai, P. N.
Social Bookmarking
What's this?
http://ecam.oxfordjournals.org/cgi/content/abstract/nep005v1?
maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&fulltext=AYURVEDA+VERS
US+ALLOPATHY&searchid=1&FIRSTINDEX=0&resourcetype=HWCIT
Associate Professor of Psychiatry, College of Medicine, University of Illinois at Chicago, and Chief of
Psychiatry, West-Side V. A. Medical Center Chicago, Illinois 60680, U.S.A.
Abstract
Medical ethics in the Indian context is closely related to indigenous classical and folk
traditions. This article traces the history of Indian conceptions of ethics and medicine,
with an emphasis on the Hindu tradition. Classical Ayurvedic texts including
Carakasamhita and Susrutasamhita provide foundational assumptions about the body, the
self, and gunas, which provide the underpinnings for the ethical system. Karma, the
notion that every action has consequences, provides a foundation for medical morality.
Conception, prolongation of one's blood-line is an important ethical aim of life. Thus a
wide range of practices to further conception are acceptable. Abortion is a more complex
matter ethically. At the end of life death is viewed in the context of passage to another
life. Death is a relief from suffering to be coped with by the thought of an eternal atman
or rebirth.
http://jmp.oxfordjournals.org/cgi/content/abstract/13/3/231?
maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&fulltext=AYURVEDA+VERS
US+ALLOPATHY&searchid=1&FIRSTINDEX=0&resourcetype=HWCIT